Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Pfizer

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

Anti-vaxxers think God destroyed a Pfizer facility with a tornado

No vaccines were produced or stored at the facility

The Independent UK

Tornado damage to Pfizer plant will probably create long-term shortages of some drugs hospitals need

U.S. hospital drug supplies may be strained further after a tornado ripped open the roof of a Pfizer factory this week

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Large Tornado Hits North Carolina, Hospitalizes Several

Interstate 95 Shut Down as Pfizer Facility Suffers Damage

Zenger

Pascal Soriot of AstraZeneca: ‘The climate crisis is a health crisis’

The man who led the drive to create a not-for-profit Covid vaccine is now focusing on the deaths caused by global heating and pollution

The Guardian - UK

New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season

U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year

The Independent UK

Elderly Nursing Home Residents Denied Life-Saving COVID Treatment, Study Finds

Inadequate use of antiviral medication led to avoidable mortality, with Paxlovid underutilized

Zenger

Read news from The Economist, FT, and more,
with one subscription

Roche Could Take A Page Out Of Merck's Playbook. Why Roivant Surged.

Roche is in discussions to buy a stomach-disease treatment from Roivant for around $7 billion. The report sent ROIV stock surging Friday.

Investors Business Daily

The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly?

An overweight world is hungry for obesity treatments, driving big forecasts for weight loss drugs. For now, two pharmaceutical stocks own the market.

Investors Business Daily

Panadol maker plans sweeping job cuts a year after being spun off from GSK

Exclusive: Consumer healthcare firm Haleon to cut hundreds of roles in UK and potentially thousands globally

The Guardian - UK

Should You Buy the Dip in Pfizer Stock? Here's What You Need to Know

US stock markets delivered stellar returns in the first half of the year and the Nasdaq 100 had its best first-half performance ever. However, Pfizer, whose COVID-19 vaccine made the company a household name recently fell to a 52-week low. Why is Pfizer stock going down and should you buy…

Barchart

Should Value Investors Watch Pfizer (PFE)?

Pfizer (PFE) is spending its COVID-19 cash flows on meaningful growth avenues. However, given a recent downgrade, should value investors still be excited about this stock? Let’s look at the trends of its financial metrics to get an idea….

StockNews.com

‘It’s naive to think this is in the best interests of the NHS.’ How Big Pharma’s millions are influencing healthcare

Observer investigation shows drug company money flows through the NHS, raising questions about conflict of interest

The Guardian - UK

2 Unusually Active Options to Buy/Sell Not Named Rivian

Rivian’s strong sales results drove the unusual options activity in Friday trading. For those who aren’t enamored with the electric vehicle manufacturer’s business, there are, pardon the pun, other options.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Daily Mirror

Health warning as cases of little known disease skyrocket and 'tripledemic' looms

Health officials are endorsing two new vaccines against respiratory syncytial virus (RSV) for older Americans, alongside flu and Covid-19 vaccines, although there are uncertainties about the risks

StockNews.com

AbbVie (ABBV) vs. Pfizer (PFE) - Which Pharma Stock Comes out on Top?

With the growing prevalence of chronic conditions, an aging population, widespread adoption of digital technologies, and several R&D efforts, the pharmaceutical industry is poised for exponential growth and expansion. So, let’s compare leading pharma stocks AbbVie (ABBV) and Pfizer (PFE) to identify which is a better investment now. Keep reading….

Axios

The plan to dodge another tripledemic

Vaccines to stave off the flu, a new COVID variant and now, respiratory syncytial virus could help avert another tripledemic this fall. Unless the public is too crisis-fatigued to care.

The Independent UK

Up to 10,000 Britons could take part in cancer vaccine trials

Participants could receive groundbreaking treatment after the Government signed an agreement with a leading pharmaceutical company.

Get all your
news in one place.

100’s of premium titles.
One news app.

Inverse

A Long-Awaited Vaccine For Lyme Disease is Tantalizingly Close — Here's When It Could Be Available

Over the past twenty years, Lyme disease cases have continued to climb, and we are finally tantalizingly close to another vaccine.

The Guardian - UK

UK regulator sued for not investigating Covid vaccine ‘misinformation’

Case brought against General Medical Council for failure to look into claimed links to heart problems and deaths

Zenger

EU Commission Secures Vaccine Production Capacity For Future Crises

Pfizer and European pharmaceutical firms to stockpile vaccines for rapid response, raising concerns over equity

Investors Business Daily

Stock Market Rebounds Toward Highs; Carnival, Delta, Micron, Nvidia In Focus: Weekly Review

The market rally had a strong week, with the major indexes rebounding toward 2023 highs and many stocks flashing buy signals.

Investors Business Daily

Being Honest And Staying Humble To Win Trust

Being honest and humble is a winning combination. But pulling both off can be tougher than it seems.

Barchart

Tech Stocks Undercut by Sharp Rise in T-note Yields on Hawkish Powell

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.31%. Stocks are being undercut by today’s hawkish Powell comments,...

Barchart

Markets Today: Stocks Higher on Positive U.S. Bank Stress Tests

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.23%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.21%. Stocks are higher this morning on U.S. economic resilience as reflected in today’s U.S. economic reports. Also, there is optimism about the U.S. banking system...

1 … 17 18 19 20

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the European Commission

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.